Literature DB >> 10762583

Traveler's diarrhea at sea: three outbreaks of waterborne enterotoxigenic Escherichia coli on cruise ships.

N A Daniels1, J Neimann, A Karpati, U D Parashar, K D Greene, J G Wells, A Srivastava, R V Tauxe, E D Mintz, R Quick.   

Abstract

Enterotoxigenic Escherichia coli (ETEC) has become the leading bacterial cause of gastroenteritis outbreaks on cruise ships. Investigation of recent outbreaks of ETEC gastroenteritis on 3 cruise ships indicated that all were associated with consuming beverages with ice cubes on board the ship (relative risk [RR], 1.4, 95% confidence interval [CI], 1.0-1.9, P=.02; RR, 1.9, 95% CI, 1.3-2. 9, P<.001; and RR, 1.3, 95% CI, 1.0-1.6, P<.01), and 2 were associated with drinking unbottled water (RR, 2.7, 95% CI, 1.8-4.1, P<.001; RR, 1.7, 95% CI, 1.3-2.3, P<.001). Multiple ETEC serotypes were detected in patients' stool specimens in each of the 3 outbreaks, and 12 (38%) of 32 isolates were resistant to > or =3 antimicrobial agents. ETEC appears to be emerging as a waterborne pathogen on cruise ships. Water bunkered in overseas ports was the likely source of ETEC infection in these outbreaks. To ensure passenger safety, cruise ships that take on water in foreign ports must ensure that water treatment and monitoring systems function properly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762583     DOI: 10.1086/315397

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Outbreaks of Gastrointestinal Diseases on Cruise Ships: Lessons from Three Decades of Progress.

Authors:  Dale N. Lawrence
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

2.  Assessment of drinking water quality using ICP-MS and microbiological methods in the Bholakpur area, Hyderabad, India.

Authors:  Rasheed M Abdul; Lakshmi Mutnuri; Patil J Dattatreya; Dayal A Mohan
Journal:  Environ Monit Assess       Date:  2011-05-05       Impact factor: 2.513

3.  Genetic Relatedness Among Escherichia coli Pathotypes Isolated from Food Products for Human Consumption in Cartagena, Colombia.

Authors:  Zorangel Amézquita-Montes; Maria Tamborski; Usa G Kopsombut; Chengxian Zhang; Octavio S Arzuza; Oscar G Gómez-Duarte
Journal:  Foodborne Pathog Dis       Date:  2015-03-18       Impact factor: 3.171

Review 4.  Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.

Authors:  Firdausi Qadri; Ann-Mari Svennerholm; A S G Faruque; R Bradley Sack
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

5.  Partially assembled K99 fimbriae are required for protection.

Authors:  Miguel A Ascón; Javier Ochoa-Repáraz; Nancy Walters; David W Pascual
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

6.  Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.

Authors:  T S Coster; M K Wolf; E R Hall; F J Cassels; D N Taylor; C T Liu; F C Trespalacios; A DeLorimier; D R Angleberger; C E McQueen
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

7.  Travellers' diarrhea in children.

Authors:  Pierre J Plourde
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

Review 8.  A review of outbreaks of waterborne disease associated with ships: evidence for risk management.

Authors:  Roisin M Rooney; Jamie K Bartram; Elaine H Cramer; Stacey Mantha; Gordon Nichols; Rohini Suraj; Ewen C D Todd
Journal:  Public Health Rep       Date:  2004 Jul-Aug       Impact factor: 2.792

9.  Real-time fluorescence PCR assays for detection and characterization of heat-labile I and heat-stable I enterotoxin genes from enterotoxigenic Escherichia coli.

Authors:  Udo Reischl; Mohammad T Youssef; Hans Wolf; Eija Hyytia-Trees; Nancy A Strockbine
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.

Authors:  Fernando Güereña-Burgueño; Eric R Hall; David N Taylor; Frederick J Cassels; Daniel A Scott; Marcia K Wolf; Zachary J Roberts; Galina V Nesterova; Carl R Alving; Gregory M Glenn
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.